Details for Patent: 7,741,356
✉ Email this page to a colleague
Which drugs does patent 7,741,356 protect, and when does it expire?
Patent 7,741,356 protects VIBERZI and is included in one NDA.
This patent has eighty-three patent family members in thirty-five countries.
Summary for Patent: 7,741,356
| Title: | Compounds as opioid receptor modulators |
| Abstract: | The present invention is directed to novel opioid receptor modulators of Formula (I). The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors. |
| Inventor(s): | Henry J. Breslin, Chaozhong Cai, Wei He, Robert W. Kavash |
| Assignee: | Janssen Pharmaceutica NV |
| Application Number: | US11/079,647 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,741,356 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 7,741,356
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | VIBERZI | eluxadoline | TABLET;ORAL | 206940-001 | May 27, 2015 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Abbvie | VIBERZI | eluxadoline | TABLET;ORAL | 206940-002 | May 27, 2015 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,741,356
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1725537 | ⤷ Start Trial | CA 2017 00008 | Denmark | ⤷ Start Trial |
| European Patent Office | 1725537 | ⤷ Start Trial | 300865 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1725537 | ⤷ Start Trial | PA2017005 | Lithuania | ⤷ Start Trial |
| European Patent Office | 1725537 | ⤷ Start Trial | 122017000009 | Germany | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
